236 related articles for article (PubMed ID: 24104936)
1. Keratoplasty postoperative treatment update.
Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
[TBL] [Abstract][Full Text] [Related]
2. Postkeratoplasty atopic sclerokeratitis in keratoconus patients.
Tomita M; Shimmura S; Tsubota K; Shimazaki J
Ophthalmology; 2008 May; 115(5):851-6. PubMed ID: 17884169
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
[TBL] [Abstract][Full Text] [Related]
5. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
[TBL] [Abstract][Full Text] [Related]
6. Large-diameter penetrating keratoplasty: indications and outcomes.
Skeens HM; Holland EJ
Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
[TBL] [Abstract][Full Text] [Related]
8. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
[TBL] [Abstract][Full Text] [Related]
9. [The effectiveness and safety of topical 0.1% tacrolimus after high-risk penetrating keratoplasty].
Li X; Zhang YN; Yin MY; Pan ZQ
Zhonghua Yan Ke Za Zhi; 2019 Jun; 55(6):419-427. PubMed ID: 31189271
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
11. Topical 0.03% tacrolimus versus systemic mycophenolate mofetil as adjuncts to systemic corticosteroids for preventing graft rejection after repeat keratoplasty: one-year results of a randomized clinical trial.
Faramarzi A; Abbasi H; Feizi S; Hadi Y; Azari AA; Karimian F; Jafarinasab MR; Kheiri B
Eye (Lond); 2021 Oct; 35(10):2879-2888. PubMed ID: 33414533
[TBL] [Abstract][Full Text] [Related]
12. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
13. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
[TBL] [Abstract][Full Text] [Related]
14. Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study.
Qi X; Wang L; Zhang X; Liu M; Gao H
BMC Ophthalmol; 2022 Mar; 22(1):101. PubMed ID: 35246084
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].
Nguyen NX; Seitz B; Langenbucher A; Wenkel H; Cursiefen C
Klin Monbl Augenheilkd; 2004 Jun; 221(6):467-72. PubMed ID: 15236106
[TBL] [Abstract][Full Text] [Related]
16. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
Reinhard T; Möller M; Sundmacher R
Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.
Dhaliwal JS; Mason BF; Kaufman SC
Cornea; 2008 May; 27(4):488-93. PubMed ID: 18434855
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
Pollock-Barziv SM; Dipchand AI; McCrindle BW; Nalli N; West LJ
J Heart Lung Transplant; 2005 Feb; 24(2):190-4. PubMed ID: 15701436
[TBL] [Abstract][Full Text] [Related]
19. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[TBL] [Abstract][Full Text] [Related]
20. [Systematic review of penetrating keratoplasty rejection treated by immunosuppressants].
Sun YJ; Li AP; Pan ZQ; Luo F; Zou LH
Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1122-7. PubMed ID: 21211228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
